Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New type of rare brittle-bone disease discovered

06.07.2016

Researchers from the University of Zurich and University Children’s Hospital Zurich have dis-covered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease. The new discovery improves the genetic diagnosis of the disease and paves the way to possible improved treatment options for patients.

Between 300 and 400 people in Switzerland and around half a million worldwide suffer from brittle-bone disease, which causes their bones to break like glass. Not only is their bone formation insuffi-cient; other body tissues containing connective tissue are also affected.


People with osteogenesis imperfecta often break their bones (image: thinkstock)

Cecilia Giunta and Marianne Rohrbach, both researchers from the Children’s Research Center at the University Children’s Hospital Zurich, their teams and colleagues from the USA and Thailand have now detected a new type of brit-tle-bone disease, identifying two families with a total of eight patients in all.

The patients suffer from heightened bone fragility, bone deformities and stunted growth. In both families, this new form of oste-ogenesis imperfecta was caused by two different mutations of the same gene (MBTPS2) in the X chromosome. The disease is inherited in an X-chromosome-recessive manner and affects men and boys as only they carry a copy of the X chromosome.

Simple test in the urine

“Exactly how common the newly discovered disease is remains unclear,” says Cecilia Giunta. “That said, it’s easy to identify other patients, as we demonstrated that the disease can be diagnosed with a simple measurement of biomarkers in the urine.”

These biomarkers indicate changes in the crosslink-ing between the structural proteins in the bone. MBTPS2 encodes a protease, i.e. a protein, which is able to cut and therefore activate other proteins – so-called transcription factors. These activated pro-teins bind to the DNA and regulate genes involved in the bone and sterol metabolism and the regula-tion of cell stress.

This was primarily shown in zebra fish in 2003. Shortly afterwards, researchers dis-covered that IFAP syndrome, a group of rare dermatological diseases in humans, is caused by muta-tions in MBTPS2.

“Surprisingly, mutations in the gene MBTPS2 also cause a completely different disease, namely oste-ogenesis imperfecta,” explains Marianne Rohrbach. The culprit is a change in the bone metabolism, which no longer seems to be impaired in the case of dermatological diseases.

Exactly how and why mutations can trigger two completely different diseases in the same gene remains unclear. The team headed by Cecilia Giunta and Marianne Rohrbach are now focusing their research on finding the an-swer. The scientists hope to gain new insights into bone developments and sterol metabolism, which could one day mean improved treatment options for patients.

Literature:
Uschi Lindert, Wayne Cabral, Surasawadee Ausavarat, Siraprapa Tongkobpetch, Katja Ludin, Aileen Barnes, Patra Yeetong, MaryAnn Weis, Birgit Krabichler, Chalurmpon Srichomthong, Elena Makaree-va, Andreas Janecke, Sergey Leikin, Benno Röthlisberger, Marianne Rohrbach, Ingo Kennerknecht, David Eyre, Kanya Suphapeetiporn, Cecilia Giunta, Joan Marini, and Vorasuk Shotelersuk. MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta. Nature Communications. DOI: 10.1038/NCOMMS11920


Contacts:
Dr. sc. nat. Cecilia Giunta
Division of Metabolic Diseases,
Children’s Research Center, Children’s Hospital Zurich
Phone: +41 266 73 10
E-mail: cecilia.giunta@kispi.uzh.ch

PD, Dr. med. et phil. nat. Marianne Rohrbach
Division of Metabolic Diseases,
Children’s Research Center, Children’s Hospital Zurich
Phone: +41 266 73 10
E-mail: marianne.rohrbach@kispi.uzh.ch

Beat Müller | Universität Zürich
Further information:
http://www.uzh.ch/

More articles from Life Sciences:

nachricht A new molecular player involved in T cell activation
07.12.2018 | Tokyo Institute of Technology

nachricht News About a Plant Hormone
07.12.2018 | Julius-Maximilians-Universität Würzburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

Im Focus: The force of the vacuum

Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.

The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

Inaugural "Virtual World Tour" scheduled for december

28.11.2018 | Event News

 
Latest News

A new molecular player involved in T cell activation

07.12.2018 | Life Sciences

High-temperature electronics? That's hot

07.12.2018 | Materials Sciences

Supercomputers without waste heat

07.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>